IVERMECTIN WITH NITAZOXANIDE ELIMINATE CRYPTOSPORIDIUM INTESTINAL INFECTION IN IMMUNOCOMPROMIZED MICE AND UPREGULATE CYTOKERATIN20 EXPRESSION, ENHANCING INTESTINAL CELLULAR HEALIN

ASSESSING THE EFFICACY OF NITAZOXANIDE IN TREATMENT OF CRYPTOSPORIDIOSIS USING PCR EXAMINATION

POTENTIAL IMMUNOMODULATORY EFFECT OF SINGLE AND COMBINED THERAPIES AGAINST CRYPTOSPORIDIUM INFECTION IN IMMUNOSUPPRESSED MOUSE MODEL

PARASITOLOGICAL ASSESSMENT OF DIFFERENT CONCENTRATIONS OF PIPERAZINE CITRATE AGAINST CRYPTOSPORIDIOSIS INFECTION IN BOTH IMMUNOCOMPETENT AND IMMUNOCOMPROMISED MICE

AMELIORATING EFFECT OF NITAZOXANIDE LOADED CHITOSAN NANOPARTICLES ON INTESTINAL DYSPLASTIC CHANGES IN IMMUNOSUPPRESSED CRYPTOSPORIDIOSIS MURINE MODEL

Evaluation of potential prophylactic and therapeutic effect of azoximer bromide (polyoxidonium) on experimental cryptosporidiosis in immunocompromised mice

EFFECT OF SOME MEDICINAL HERBS VERSUS NITAZOXANIDE ON CRYPTOSPORIDIUM PARVUM INFECTED IMMUNOSUPPRESSED MICE

Effect of Silver Nanoparticles loaded Nitazoxanide in The Treatment of Murine Cryptosporidiosis in Immunocompetent and Immunosuppressed Mice

PROPHYLACTIC ANTICRYPTOSPORIDIAL ACTIVITY OF ATORVASTATIN VERSUS NITAZOXANIDE ON EXPERIMENTALLY INFECTED IMMUNOSUPPRESSED MURINE MODELS

DAFLON AS A NEW DRUG IN TREATING MURINE EXPERIMENTAL CRYPTOSPORIDIOSIS